A detailed history of Core Alternative Capital transactions in Pfizer Inc stock. As of the latest transaction made, Core Alternative Capital holds 7,948 shares of PFE stock, worth $211,575. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,948
Previous 7,448 6.71%
Holding current value
$211,575
Previous $208,000 10.58%
% of portfolio
0.05%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $13,850 - $15,695
500 Added 6.71%
7,948 $230,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $79,430 - $91,211
-3,068 Reduced 29.17%
7,448 $206,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $29,814 - $38,725
1,141 Added 12.17%
10,516 $302,000
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $417 - $487
13 Added 0.14%
9,375 $310,000
Q2 2023

Jul 27, 2023

SELL
$36.12 - $41.79 $36,878 - $42,667
-1,021 Reduced 9.83%
9,362 $343,000
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $312,402 - $406,701
7,931 Added 323.45%
10,383 $423,000
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $7,556 - $9,864
-181 Reduced 6.87%
2,452 $125,000
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $6,870 - $8,386
157 Added 6.34%
2,633 $115,000
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $17,634 - $20,909
379 Added 18.07%
2,476 $130,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $59,383 - $73,583
1,298 Added 162.45%
2,097 $109,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $3,718 - $5,512
90 Added 12.69%
799 $47,000
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $27,828 - $35,747
709 New
709 $30,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.